Vanberra Signal
VFinance logo

VFinance

Curated by Signal

Business payments solutions provider streamlining transactions for diverse industries.

Overview

VFinance operates as a business payments solutions provider, offering a suite of services designed to streamline financial transactions for companies in sectors such as logistics, e-commerce, and real estate. The platform focuses on cash receipts and payments services, facilitating payment processing through electronic invoicing, automated accounts payable and receivable, and cross-border transactions. VFinance utilizes technologies such as AI and blockchain to enhance transaction speed and cash flow visibility, providing real-time financial analytics. This aims to assist businesses in optimizing their payment operations and financial strategies, addressing the need to align financial output with operational goals.

Key facts

Founded
2013
Headquarters
Milan, Italy
Sector
Payments

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Payments companies
  • Business payments solutions provider streamlining transactions for US companies.

    PaymentsAustin, United States
  • Business payments solutions provider enabling usage-based pricing and analytics.

    PaymentsSan Jose, United States
  • Business payments solutions provider simplifying cross-border transactions for companies.

    PaymentsMumbai, India
+ 468 more similar companies on Signal

About VFinance

What does VFinance do?

VFinance operates as a business payments solutions provider, offering a suite of services designed to streamline financial transactions for companies in sectors such as logistics, e-commerce, and real estate.

Where is VFinance headquartered?

VFinance is headquartered in Milan, Italy.

When was VFinance founded?

VFinance was founded in 2013.

Which sector is VFinance in?

VFinance operates in Payments, part of Financial Technology.

Who are VFinance's competitors?

Companies similar to VFinance include AppBrilliance, Amberflo, and Winvesta.